baber/WOPTO huggingface dataset:
Patent CA-2510608-A1 (CA)
Inventor: DAVENPORT FRANCIS L
IPC: D04H3/04
Filed: 2003-11-06
Abstract: A method for manufacturing a papermaker's or industrial fabric with improved functional properties such as permeability and abrasion resistance is disclosed. These improved functional properties are imparted by the application of a polymeric resin material onto preselected locations on a bare substrate using a piezojet array which deposits the polymeric resin material in droplets having an average diameter of 10µ  (10 microns) or more. The preselected locations, for example, may be knuckles formed by the interweaving of the yarns making up the fabric or interstices between the yarns. The polymeric resin material is set by means appropriate to its composition, and, optionally, may be abraded to provide the polymeric resin material above the surface plane of the base substrate with a uniform thickness.
Patent CA-2511079-A1 (CA)
Title: Preconcentration interface coupling liquid chromatography to capillary electrophoresis
Inventor: CURCIO MARIO
IPC: G01N1/40
Filed: 2005-06-29
Abstract: An arrangement for two-dimensional separation of a complex analyte mixture, e.g. of peptides, comprises a first separation device for the separation in a first dimension and a second device for the separation in the second dimension. In the area of the interface between the first and the second device a concentration zone is arranged for concentrating the individual sample fractions or components, respectively, leaving the first device before introduction into the second device. The concentration zone is defined in a segment between two or more electrodes seen in flow direction of the sample or sample fractions to be separated. The concentration is achieved by applying a voltage between two electrodes with polarity opposite to the charge of the components of the fraction, sufficiently strong to win the dragging force of the hydrodynamic flow.      The introduction into the second device is carried out by turning off the potential difference between the electrodes.
Patent CA-2511221-A1 (CA)
Inventor: KURODA MASAHARU
IPC: A23L7/10
Filed: 2003-12-09
Abstract: It is intended to provide a method of reducing the total amount of stored protein, to develop a technique required therefor, and to provide a plant and its seeds developed by the above method and a method of using such a plant and seeds. More specifically, a nucleic acid molecule containing a consecutive nucleic acid sequence of at least 15 in length which is complementary with a nucleic acid sequence encoding prolamine polypeptide or a nucleic acid sequence having a homology of at least about 70% to the complementary nucleic acid sequence having at least 15 nucleotide length. A method of reducing the expression dose of a protein in a seed of a plant which comprises: A) the step of providing the above-described nucleic acid molecule; B) the step o transferring the nucleic acid molecule into the cells of the plant; C) the step of re-differentiating the cells to construct a transgenic plant; and D) the step of obtaining seeds from the transgenic plant.
Patent CA-2512188-A1 (CA)
Inventor: HANSEN HANS
IPC: A61K51/10
Filed: 2003-12-31
Abstract: The invention is directed to a method for treating a treating and diagnosing a B cell-related disease, T cell-related disease or an autoimmune disease in a mammal by concurrently or sequentially administering to the mammal a therapeutic composition that comprises a pharmaceutically acceptable vehicle and at least one conjugated antibody, wherein predosing with a non-radiolabeled antibody is not performed.
Patent CA-2513907-A1 (CA)
Inventor: VANBLAERE ROLAND FRANS CYRILLE
IPC: B65D83/14
Filed: 2004-01-20
Abstract: A pressure package system for providing a working pressure on a fluid included in a pressure package, the system being provided with a pressure package (2) in which a product chamber (4) is included for holding the fluid and in which a working pressure chamber is included for keeping a propellant at the working pressure, the system being further provided with a pressure controller (5) and a high-pressure chamber (6) connected with the pressure controller for keeping the propellant in supply at a relatively high pressure, the pressure package system being further provided with a wall (7) which is of elastic and/or flexible design, a first side (8) of the wall bounding the working pressure chamber at least partly and a second side (9) of the wall, facing away from the working pressure chamber, bounding the product chamber at least partly.
Patent CA-2514896-A1 (CA)
Title: Derivatives of seleno-amino acids with improved bioavailability and method for assuring adequate dietary requirements of selenium for livestock
Inventor: ANDERSON MICHAEL D
IPC: A23K1/16
Filed: 2003-12-10
Abstract: Metal L-seleno-alpha-amino acids salts and their use as a bioavailable feed and water ration supplement for domesticated animals such as cattle, pigs and poultry.
Patent CA-2514946-A1 (CA)
Title: Method for producing a polymer system capable of proton exchange, based on polyaryl ether ketones
Inventor: HENNIG INGOLF
IPC: H01M8/10
Filed: 2004-02-27
Abstract: The invention relates to a method for producing a polymer system capable of proton exchange, based on at least one polyaryl ether ketone. Said method consists of: (i) reacting the polyaryl ether ketone(s) with at least one alkane sulphonic acid, to obtain polyaryl ether ketones (I) containing sulphur. The invention also relates to sulphonated polyaryl ether ketones, which can be produced according to the inventive method and to their use as a polymer electrolyte membrane.
Patent CA-2515775-A1 (CA)
Inventor: GEARY ROBERT
IPC: B64D13/06
Filed: 2004-02-17
Abstract: Method and arrangement for adjusting nitrogen and oxygen concentrations within regions of an aircraft. The method includes separating nitrogen from ambient air onboard an aircraft thereby establishing a high-concentration nitrogen supply and then dispensing high-concentration nitrogen from the supply to a fire-susceptible, non-habitable region of the aircraft where the high-concentration nitrogen is reservoired thereby decreasing the capability for the atmosphere therein to support combustion. Oxygen is also separated from the ambient air thereby establishing a high-concentration oxygen supply that is dispensed to an occupant cabin of the aircraft thereby increasing the level of oxygen concentration within the cabin to a level greater than the naturally occurring concentration of oxygen at the experienced internal cabin pressure.  When it is determined that reduced oxygen concentration is required in the occupant cabin, the reservoired high-concentration nitrogen is moved into the passenger cabin diluting the oxygen-elevated environment.
Patent CA-2518140-A1 (CA)
Inventor: LUEHRS DOUGLAS R
IPC: H04N7/173
Filed: 2004-03-15
Abstract: A video on demand (VOD) system (100) for use in a distributed network environment. The distributed network environment contains a number of geographic networks (400A-400N) that are divided into a plurality of tiers (305-1 to 305-N), which are allocated to content providers (225). A content provider (225) provides content to the network with a tier assignment. The content is received pursuant to the assigned tier. Identification information, such as Categorization Information, is provided with and/or associated with a content file. The identification information may be updated at any time, independently of the content.
Patent CA-2519356-A1 (CA)
Title: Combination jump starter and high-frequency charger
Inventor: KRIEGER MICHAEL
IPC: H01M50/251
Filed: 2004-03-22
Abstract: A portable jump starter/charger combination includes a housing and a jump starter battery enclosed within the housing for providing a first DC output. A  battery charger is also enclosed within the housing and provides a second DC  output. A function selector switch has a first input coupled to the first DC  output of the jump starter battery, a second input coupled to the second DC  output of the charger and an output coupled to battery cables. The function selector switch is operative to selectively connect one of the first and second inputs to the output of the function selector for either jump starting a vehicle with a dead battery or charging the dead battery through the pair of battery cables.
Patent CA-2522495-A1 (CA)
Inventor: PRIVETT STEPHEN
IPC: H03F3/217
Filed: 2004-03-19
Abstract: The invention relates to a distributed audio system, and an amplifier arrangement therefor, which is configured so that the remotely powered switching amplifier and power supply arrangement reduces heat dissipation and increase the efficiency when powered over, particularly but not exclusively, small gauge structured wiring cables.
Patent CA-2526898-A1 (CA)
Inventor: GASSNER DIETER
IPC: C12Q1/37
Filed: 2004-06-22
Abstract: The invention relates to methods for detecting infectious or pathogenic prion protein with improved sensitivity. According to the invention, a protease-resistant prion protein PrPSc is freshly formed by a spontaneous transformation reaction by means of interaction of non-pathogenic prion protein PrPc in the sample with low-molecular protease-sensitive PrPSc aggregates, in order to form high-molecular protease-resistant PrPSc aggregates.
Patent CA-2529356-A1 (CA)
Inventor: MCFETRIDGE KELLY
IPC: G09F19/22
Filed: 2005-11-14
Abstract: A window display apparatus comprising a sheet of material having a peripheral edge, opposed ears integrally formed out of the sheet of material, the opposed ears projecting in opposed relation past the peripheral edge of the sheet of material, and suction cups mounted on the opposed ears.
Patent CA-2531750-A1 (CA)
Title: Synthetic method for the preparation of quinazolin-4-one derivative
Inventor: GODFREY ANDREW AYDON
IPC: C07C255/60
Filed: 2004-07-20
Abstract: A quinazolin-4-one derivative of formula (I), may be made by a process including the step of cyclization an amide of formula (II), to form a quinazolin-4-one derivative of formula (III).
Patent CA-2532084-A1 (CA)
Inventor: HIRSCH ALEC
IPC: A61K31/7115
Filed: 2004-04-15
Abstract: Applicants have used microarrays, gene expression profiling, and gene silencing methods to identify and provide a plurality of 'validated' virus-induced cellular gene sequences (e.g., HMG20B, HRH1, NP and c-YES (src family kinases)) and pathways useful as therapeutic targets for modulation of viral-mediated cellular effects. Particular embodiments provide therapeutic compositions, and methods for modulation of viral infection, replication, maturation, progression, or other virally-related conditions or diseases, comprising inhibition of virally-induced gene sequences and gene products.  Additional embodiments provide screening assays for compounds useful to modulate viral infection, replication, maturation or progression, or viral-related conditions or diseases. Further embodiments provide diagnostic and/or prognostic assays for viral infection, replication, maturation or progression.  Preferably, the viruses all selected from the group consisting of retroviruses (e.g., human immunodeficiency virus (HIV), and viruses of the family Flaviviridae that includes the flaviviruses (e.g., West Nile virus (WNV), Japanese encephalitis virus (JEV), yellow fever virus (YFV) and Dengue fever virus (DEN)), and hepatitis C virus (HCV).
Patent CA-2535064-A1 (CA)
Title: Materiau multi-couches, procede de fabrication et utilisation comme electrode
Inventor: CHAREST PATRICK
IPC: B32B7/10
Filed: 2006-02-01
Abstract: Matériaux multi-couches comportant un support solide et au moins deux couche s superposées solides qui contiennent des particules d'un matériau électrochimiquement actif. Ces matériaux multi-couches se caractérisent notamment par une faible interpénétration ent re couches solides adjacentes. Procédés de préparation des matériaux multi-couches de l'invention, notamment ceux qui comportent une étape d'épandage d'un mélange comportant des particules d e matériaux électrochimiquement actifs. Electrodes multi-couches obtenues par le procédé de l'invention et qui présentent des propriété mécaniques et électrochimiques remarquables. Générateurs électrochimiques qui incorporent au moins une électrode à base d'un matériau multi-couches de l'invention et qui se caractérisent par une sécurité exceptionnelle. Ces générateurs sont particulièrement adaptés pour une utilisation dans les systèmes électronique s portables et dans les véhicules hybrides, notamment grâce à une forte résistance en présence d e surcharge.
Patent CA-2537062-A1 (CA)
Title: Manufacturing process for liquid crystalline polymer
Inventor: JACKSON RICHARD A
IPC: C08G63/91
Filed: 2004-09-03
Abstract: The properties of a liquid crystalline polymer (LCP) containing ester linkages and made in the presence of an excess of diol are improved by treating the LCP  with a dicarboxylic acid at elevated temperature. The resulting LCPs are useful as molding resins and for films.
Patent CA-2538071-A1 (CA)
Title: Dual-function light guide for lcd backlight
Inventor: ROBINSON JAMES
IPC: G09G3/36
Filed: 2006-02-28
Abstract: A portable computing device includes a housing having an external surface, and an event notifier, a display device, and a light controller disposed within the housing. The event notifier includes an event notification lamp, and a light conduit terminating at the external surface for conveying light between the event notification lamp and the external surface.  The display device includes illumination means for improved visualization of information rendered on the display device. The light controller is coupled to the event notifier and the illumination means. The light controller is configured to determine the intensity of ambient light external to the housing via the light conduit, and to adjust the intensity of light emitted by the illumination means in accordance with the determined ambient light intensity.
Patent CA-2538335-A1 (CA)
Title: Fluorescent lamp with reduced end blackening and mount therefor
Inventor: HORION PASCAL
IPC: H01J17/22
Filed: 2006-03-01
Abstract: A fluorescent lamp (10) has an elongated glass envelope (12) with a mount structure (14) sealing each end (16) of the envelope (12). The mount structure (14) comprises a glass base (18) with two spaced apart lead-in wires (20, 22) sealed into the glass base (18) and extending into the envelope (12). An electrode (24) is connected between the lead-in wires (20, 22) within the envelope (12) and an electrode shield (26) surrounds the electrode (24). The electrode shield (26) has an open top (26a) and an open bottom (26b) and a wall (26c) that is substantially equidistantly spaced from the electrode (24). A support member (28) is attached only to the shield wall (26c) and to one of the lead-ins, for example, (22), thereby making the shield (26) electrically active when the lamp is operating.
Patent CA-2539441-A1 (CA)
Title: Systems and methods for staging transactions, payments and collections
Inventor: MOORE GARY
IPC: G06Q30/00
Filed: 2004-09-15
Abstract: The present invention relates to systems and methods for staging transactions and facilitating payments by consumers to a lender or merchant to consummate a financial transaction and/or to maintain a financial relationship. In one embodiment, a method for accepting payments from a consumer includes receiving a promise-to-pay record from a lender (210), receiving a payment from the consumer (220), associating the payment with the promise-to-pay record (230), and sending a notice to the lender (240), with the notice having an indicator that the payment has been received.
Patent CA-2539906-A1 (CA)
Title: Microgels in non-crosslinkable organic media
Inventor: OBRECHT WERNER
IPC: C08K5/01
Filed: 2004-09-23
Abstract: The invention relates to a composition containing a specific non-crosslinkable medium and at least one microgel. The invention also relates to methods for producing said composition, to uses of the same, and to microgel-containing polymers, rubber, lubricants, coatings etc. produced therefrom.
Patent CA-2542761-A1 (CA)
Title: Analgesia method
Inventor: NADESON RAYMOND
IPC: A61K31/573
Filed: 2004-10-15
Abstract: Opioid tolerance is reduced by treating the patient with a neurosteroid of formula (I) wherein R1 is H or methyl; R2 is OH and R3 is H, or R2 and R3 taken together are O; R4 is H or methyl; R5 and R6 are each H, or R5 and R5 taken together are O; R7 is H or methyl; and R8 is H, OH, -OC(=O)CH3, SH, -SC(=O)CH3, Cl, Br or F.
Patent CA-2543606-A1 (CA)
Title: Resolution of 3-amino alkylnitriles
Inventor: COLBERG JUAN CARLOS
IPC: A61K31/4172
Filed: 2004-10-18
Abstract: The present invention relates to chiral N-acetyl-alpha-amino acid salts of optically active .beta.-amino alkylnitriles, and also to a process for preparing optically active .beta.-amino alkylnitriles by resolving racemic .beta.-amino alkylnitriles using chiral N-acetyl-alpha-amino acids as resolving agent.
Patent CA-2543830-A1 (CA)
Inventor: SINGH SHARAT
IPC: G01N33/543
Filed: 2004-10-25
Abstract: L'invention concerne un procédé de détection d'anticorps anti-anticorps thérapeutique chez un patient traité par anticorps thérapeutique. Selon un aspect, les étapes sont les suivantes: (i) fourniture d'un premier anticorps thérapeutique sur lequel est fixé une étiquette moléculaire via une liaison clivable, cette étiquette ayant une ou plusieurs caractéristiques de séparation préétablies; (ii) fourniture d'un second anticorps thérapeutique sur lequel est fixée une fraction à induction de clivage, laquelle a une proximité efficace; (iii) combinaison dans un mélange d'essai entre l'échantillon, le premier anticorps thérapeutique et le second anticorps thérapeutique, dans des conditions telles que les deux anticorps forment un complexe avec un anticorps antithérapeutique, sachant que la liaison clivable du premier anticorps est à proximité efficace de la fraction à induction de clivage du second anticorps et que des étiquettes moléculaires sont libérées; et (iv) séparation et détection, dans le mélange d'essai, de ces étiquettes libérées pour déterminer la présence ou l'absence d'anticorps antithérapeutique.
Patent CA-2544055-A1 (CA)
Title: Fuel cell end plate assembly
Inventor: O'BRIEN DENNIS P
IPC: H01M8/00
Filed: 2004-10-13
Abstract: Fuel cell systems incorporate end plate assemblies used to compress the fuel cell stack and/or to collect current from the fuel cell stack. A fuel cell system includes a fuel cell stack having fuel cells stacked in a predetermined stacking direction. Multi-function or multi-region compression end plate assemblies are disposed at the ends of a fuel cell stack. A multi-region compression end plate assembly involves compression mechanisms configured to preferentially compress separate areas of the fuel cell stack. A multi-function end plate assembly employs a current collector passing through an end plate to collect current from the fuel cell stack. The current collector may be used to preferentially compress a region of the fuel cell stack.
Patent CA-2544711-A1 (CA)
Inventor: ROTTHAEUSER MAGDALENA
IPC: E21B47/00
Filed: 2004-12-31
Abstract: The invention aims at providing fast and exact information from the drilling site during deep drillings. To this aim, a measuring device (6) having an electrically operated measuring unit is used to measure relevant data of the rock, the drilling fluid and/or the raw material to be extracted, wherein the measuring device (6) is configured to supply electric energy by means of the drill stems (3) and to transfer data to the surface equally by means of the drill stems (3).
Patent CA-2545026-A1 (CA)
Title: Paper handling system feeder adjustment for stack elevator mechanisms
Inventor: STEMMLE DENIS J
IPC: B41L21/02
Filed: 2006-04-27
Abstract: An arrangement for setting side guides in the correct position for media feeders in a paper handling system which results in significant improvement in the performance of the system.
Patent CA-2545065-A1 (CA)
Title: Method of identifying responders to treatment with insulin sensitizers
Inventor: WAGNER JOHN A
IPC: A61K49/00
Filed: 2004-11-04
Abstract: A patient who is a responder to a therapeutic treatment for insulin resistance or for one or more diseases associated with type 2 diabetes can be identified by the method of measuring the amount of HMW adiponectin and the amount of total adiponectin or LMW adiponectin in the patient's tissue (usually plasma or serum) before the therapeutic treatment commences; then commencing the therapeutic treatment; and finally measuring the amount of HMW adiponectin and the amount of either total adiponectin or LMW adiponectin in the patient's plasma or serum one or more times after commencement of the therapeutic treatment. The patient is predicted to be a responder to the therapeutic treatment if the ratio of the amount of HMW adiponectin to the amount of total adiponectin or LMW adiponectin increases after the therapeutic treatment commences.
Patent CA-2545357-A1 (CA)
Inventor: MENANTEAU STEPHANIE
IPC: A23G1/00
Filed: 2004-11-15
Abstract: A liquid-filled confectionery composition (10), comprising a liquid-containing core (11, 12), an outer layer of confectionery coating (14, 15), and an intermediate protective layer (13) between the core (11, 12) and outer layer (14, 15). The liquid-containing core consists of a liquid (11) contained within a water soluble or biodegradable matrix (12). The edible water impermeable intermediate layer (13) is applied in alcohol and prevents the movement of water between the core (11, 12) and the outer layer (14, 15), thereby preventing the core (11, 12) from drying out.
Patent CA-2546669-A1 (CA)
Title: Sequence-specific inhibition of small rna function
Inventor: HUTVAGNER GYOERGY
IPC: C12Q1/68
Filed: 2004-11-26
Abstract: The present invention relates to the discovery of a method for inhibiting RNA  silencing in a target sequence-specific manner. RNA silencing requires a set of conserved cellular factors to suppress expression of gene-encoded polypeptide. The invention provides compositions for sequence-specific inactivation of the RISC component of the RNA silencing pathway, and methods of use thereof. The RISC inactivators of the present invention enable a variety of methods for identifying and characterizing miRNAs and siRNAs, RISC-associated factors, and agents capable of modulating RNA silencing.  Therapeutic methods and compositions incorporating RISC inactivators and therapeutic agents identified through use of RISC inactivators are also featured.
Patent CA-2547320-A1 (CA)
Title: Fatty acid elongase (fae) genes and their utility in increasing erucic acid and other very long-chain fatty acid proportions in seed oil
Inventor: MIETKIEWSKA ELZBIETA
IPC: C12N15/82
Filed: 2004-11-24
Abstract: This invention relates to seeds of plant, plants themselves and cells of suc h plants which comprise a heterologous gene coding for a plant (such as nasturtium (Tropaeolum majus) or Crambe abyssinica) fatty acid elongase (FAE ) gene or allelic variant thereof, or combinations of one or both of these FAE genes with an Arabidopsis fatty acid elongase 1 (FAEI) gene, in co- transformation, in reading frame alignment with a promoter capable of increasing expression of said gene(s), when said transformed plant cell is i n a seed, said plant cell or seed being capable of producing an increase in proportion of a very long chain monounsaturated or saturated fatty acids whe n compared with the proportions of said fatty acids in a control plant cell or seed lacking said heterologous FAE gene or genes. The invention also relates to combinations of these fatty acid elongase genes by traditional crossing, sufficient to increase the proportion of very long chain monounsaturated or saturated fatty acids in the seed oil of the progeny compared to the proportion of said fatty acids in either of the parental lines.